Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Qianyi Fan"'
Publikováno v:
Microorganisms, Vol 12, Iss 9, p 1787 (2024)
Nitrification inhibitors like 3,4-dimethylpyrazole phosphate (DMPP) are crucial in agriculture to reduce nitrogen losses. However, the efficacy of DMPP varies in different soils. This microcosm incubation study with six soils was conducted to elucida
Externí odkaz:
https://doaj.org/article/2c8cd0d16ac348708df7109e90a64af0
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Nitrification inhibitor (NI) is often claimed to be efficient in mitigating nitrogen (N) losses from agricultural production systems by slowing down nitrification. Increasing evidence suggests that ammonia-oxidizing archaea (AOA) and ammonia-oxidizin
Externí odkaz:
https://doaj.org/article/3e048dffebd34cb19d54247251f11bd1
Autor:
Ke Huang, Na Li, Yingwen Li, Jiafeng Zhu, Qianyi Fan, Jiali Yang, Yinjia Gao, Yupin Liu, Qiangbo Hou, Shufeng Gao, Ke Wei, Chao Deng, Chijian Zuo, Zhenhua Sun
mRNA vaccines have emerged as a most promising and potent platform in the fight against various diseases including the COVID-19 pandemic. However, the intrinsic instability, varying side effects associated with the delivery systems, and continuous em
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6863ea5db0683946fea2335c183b31b
https://doi.org/10.1101/2022.05.12.491597
https://doi.org/10.1101/2022.05.12.491597
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 329
The chemotherapy toward glioblastoma (GBM) is severely challenged by blood-brain barrier and dose-limiting toxicity. Herein, we adopt brain delivery of Plk1 inhibitor volasertib (Vol), which is highly specific and presents low off-target toxicity, as
Autor:
Fenghua Meng, Yaohua Wei, Chao Deng, Xiaolei Gu, Qianyi Fan, Zhiyuan Zhong, Guanglin Wang, Zhehong Zhu
Publikováno v:
Small (Weinheim an der Bergstrasse, Germany). 15(45)
Future healthcare requires development of novel theranostic agents that are capable of not only enhancing diagnosis and monitoring therapeutic responses but also augmenting therapeutic outcomes. Here, a versatile and stable nanoagent is reported base
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 301
The clinical success of nanomedicines demands on the development of simple biodegradable nanocarriers that can efficiently and stably encapsulate chemotherapeutics while quickly release the payloads into target cancer cells. Herein, we report that cR